SYNCOM FORMULATIONS (INDIA)
Back to Income Statement
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Revenue History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2017 | Mar2016 | |
---|---|---|---|---|---|
Net Sales | ₹263 Cr | ₹224 Cr | ₹220 Cr | ₹185 Cr | ₹184 Cr |
What is the latest Revenue of SYNCOM FORMULATIONS (INDIA) ?
Year | Revenue |
---|---|
Mar2024 | ₹263 Cr |
Mar2023 | ₹224 Cr |
Mar2022 | ₹220 Cr |
Mar2017 | ₹185 Cr |
Mar2016 | ₹184 Cr |
How is Revenue of SYNCOM FORMULATIONS (INDIA) Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹263 Cr | 17.45 | |
Mar2023 | ₹224 Cr | 2.09 | |
Mar2022 | ₹220 Cr | 18.85 | |
Mar2017 | ₹185 Cr | 0.50 | |
Mar2016 | ₹184 Cr | - |
Compare Revenue of peers of SYNCOM FORMULATIONS (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SYNCOM FORMULATIONS (INDIA) | ₹1,698.6 Cr | -1.1% | -6.2% | 12.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹393,731.0 Cr | -4.1% | -2.1% | -5.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹172,373.0 Cr | -2.8% | -5.9% | 29.2% | Stock Analytics | |
CIPLA | ₹122,411.0 Cr | -3.7% | 0.1% | -2.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,285.0 Cr | -4.1% | 7.3% | 14.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹102,270.0 Cr | -5.7% | -6.1% | -11.6% | Stock Analytics |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SYNCOM FORMULATIONS (INDIA) | -1.1% |
-6.2% |
12.4% |
SENSEX | 0.2% |
-2.7% |
-0.9% |
You may also like the below Video Courses